000 01430 a2200493 4500
005 20250513162137.0
264 0 _c19990204
008 199902s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.52.1.176
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAngelini, C
245 0 0 _aThe clinical spectrum of sarcoglycanopathies.
_h[electronic resource]
260 _bNeurology
_cJan 1999
300 _a176-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aCytoskeletal Proteins
_xgenetics
650 0 4 _aDisease Progression
650 0 4 _aDystroglycans
650 0 4 _aFemale
650 0 4 _aGenetic Testing
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMembrane Glycoproteins
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aMovement
650 0 4 _aMuscular Dystrophies
_xgenetics
650 0 4 _aMutation
650 0 4 _aNeurologic Examination
650 0 4 _aPhenotype
650 0 4 _aPrognosis
650 0 4 _aSarcoglycans
650 0 4 _aSeverity of Illness Index
700 1 _aFanin, M
700 1 _aFreda, M P
700 1 _aDuggan, D J
700 1 _aSiciliano, G
700 1 _aHoffman, E P
773 0 _tNeurology
_gvol. 52
_gno. 1
_gp. 176-9
856 4 0 _uhttps://doi.org/10.1212/wnl.52.1.176
_zAvailable from publisher's website
999 _c9883545
_d9883545